Guidance for healthcare professionals on the hexavalent vaccine programme for babies born after 1 August 2017.
From autumn 2017, all babies born on or after 1 August 2017 will become eligible for a hexavalent vaccine which includes hepatitis B (HepB) for their primary immunisations. This vaccine, called Infanrix hexa®, will replace the pentavalent infant vaccines Infanrix®-IPV+Hib and Pediacel®.
This guidance is intended to provide healthcare professionals with more information about vaccinating high risk infants in light of the new universal hepatitis B infant programme.